Epidermal growth factor (EGF) binds EGFR, while heregulin (HRG) binds HER3 and HER4, and all three receptors dimerize with HER2 as the preferred co-receptor in HER2+ breast cancer cells, thus increasing HER2 activity [36]. The gene discussed is ERBB4; the disease is breast cancer.